Clinical trial
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in…
NCT00240370 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00240370 |
|---|---|
| Title | A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics |
| Official title | A Phase 3, Randomized, Double-Blind, Active-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Compared to Pioglitazone in Combination With Metformin in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Muraglitazar |
| Enrollment | 1,159 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Sep 14, 2010 |
| Countries | Canada, Mexico, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: